Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Nicotinate phosphoribosyltransferase (NAPRT) (N-Term) Peptide

NAPRT Reactivité: Humain, Souris Hôte: Synthetic BP, WB
N° du produit ABIN980491

Aperçu rapide pour Nicotinate phosphoribosyltransferase (NAPRT) (N-Term) Peptide (ABIN980491)

Antigène

NAPRT1 (NAPRT) (Nicotinate phosphoribosyltransferase (NAPRT))

Origine

Humain, Souris

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Séquence

    RLIAGPDKKL LEMGLRRAQG PDGGFTASIY SYLGGFDSSS NTLAGQLRGV

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-Naprt1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    NAPRT1 (NAPRT) (Nicotinate phosphoribosyltransferase (NAPRT))

    Sujet

    Naprt1 catalyzes the conversion of nicotinic acid (NA) to NA mononucleotide (NaMN). It is essential for NA to increase cellular NAD levels and prevent oxidative stress of the cells.

    Alias Symbols: 9130210N20Rik

    Protein Size: 538

    Poids moléculaire

    58 kDa

    ID gène

    223646

    NCBI Accession

    NM_172607, NP_766195

    UniProt

    Q8CC86
Vous êtes ici:
Chat with us!